Pages that link to "Q36565055"
Jump to navigation
Jump to search
The following pages link to Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy (Q36565055):
Displaying 50 items.
- Free radicals and antioxidants in normal physiological functions and human disease (Q21710698) (← links)
- Protein Kinase Cα Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy (Q23913471) (← links)
- Myotrophin-kappaB DNA interaction in the initiation process of cardiac hypertrophy (Q24298140) (← links)
- Protein kinase cascades in the regulation of cardiac hypertrophy (Q24518494) (← links)
- Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways (Q24649132) (← links)
- PKC translocation and ERK1/2 activation in compensated right ventricular hypertrophy secondary to chronic emphysema (Q24810204) (← links)
- How exercise may amend metabolic disturbances in diabetic cardiomyopathy (Q26863272) (← links)
- Protein kinase C mechanisms that contribute to cardiac remodelling (Q28075729) (← links)
- PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression (Q28200094) (← links)
- Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization (Q28504628) (← links)
- Involvement of protein kinase C beta 2 in c-myc induction by high glucose in pancreatic beta-cells (Q28566691) (← links)
- PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) (Q28567395) (← links)
- Akt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4,5-bisphosphate depletion (Q28571127) (← links)
- N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats (Q28573358) (← links)
- C2 domains of protein kinase C isoforms alpha, beta, and gamma: activation parameters and calcium stoichiometries of the membrane-bound state (Q28613889) (← links)
- Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3 (Q28730834) (← links)
- CapZ dynamics are altered by endothelin-1 and phenylephrine via PIP2- and PKC-dependent mechanisms. (Q30436192) (← links)
- Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. (Q30479148) (← links)
- Pleiotropy, homeostasis, and functional networks based on assays of cardiovascular traits in genetically randomized populations (Q30501139) (← links)
- PKCβII modulation of myocyte contractile performance (Q30524184) (← links)
- The potential role of PKC beta in diabetic retinopathy and macular edema (Q31123344) (← links)
- Regulation of the ligand binding activity of the human very low density lipoprotein receptor by protein kinase C-dependent phosphorylation (Q31442067) (← links)
- Brief rapid pacing depresses contractile function via Ca(2+)/PKC-dependent signaling in cat ventricular myocytes (Q31722171) (← links)
- Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation (Q33214227) (← links)
- Expression of protein kinase C isoforms in cultured human retinal pigment epithelial cells (Q33264526) (← links)
- HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study (Q33361587) (← links)
- Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats. (Q33576908) (← links)
- Signaling pathways mediating the response to hypertrophic stress in the heart. (Q33706919) (← links)
- Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets? (Q33807091) (← links)
- Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse (Q33858191) (← links)
- Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists (Q33883079) (← links)
- Deficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunction (Q33899819) (← links)
- Identification of PKC-isoform-specific biological actions using pharmacological approaches (Q33901025) (← links)
- Meeting Koch's postulates for calcium signaling in cardiac hypertrophy (Q33919182) (← links)
- A positive feedback loop contributes to the deleterious effects of angiotensin (Q34078545) (← links)
- Therapeutic potential of endothelin receptor antagonists in diabetes (Q34090982) (← links)
- Protein kinase C activation and its pharmacological inhibition in vascular disease (Q34097328) (← links)
- Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes (Q34372508) (← links)
- Highly Specific Modulators of Protein Kinase C Localization: Applications to Heart Failure (Q34386778) (← links)
- Cardiac hypertrophy and failure: lessons learned from genetically engineered mice (Q34418993) (← links)
- Coronary microvascular dysfunction in diabetes mellitus: A review (Q34427072) (← links)
- Molecular biology of protein kinase C signaling in cardiac myocytes (Q34444556) (← links)
- Protein kinase C and the development of diabetic vascular complications (Q34570516) (← links)
- Selective deletion of long but not short Cypher isoforms leads to late-onset dilated cardiomyopathy. (Q34766977) (← links)
- Kinases as therapeutic targets for heart failure (Q35058555) (← links)
- βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure (Q35103455) (← links)
- PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses (Q35106609) (← links)
- Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats (Q35167070) (← links)
- Endothelins in chronic diabetic complications. (Q35168430) (← links)
- Molecular interplay between mechanical and humoral signalling in cardiac hypertrophy (Q35226328) (← links)